Aprepitant Capsules and Carbamazepine Extended-Release Capsules (Equetro)
Determining the interaction of Aprepitant Capsules and Carbamazepine Extended-Release Capsules (Equetro) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:CarBAMazepine may reduce the blood levels and effects of aprepitant. Contact your doctor if your symptoms worsen or your condition changes during treatment with these medications. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with inducers of CYP450 3A4 may decrease the plasma concentrations of aprepitant, which is primarily metabolized by the isoenzyme. According to the product labeling, administration of a single 375 mg dose of aprepitant on day 9 of treatment with the potent CYP450 3A4 inducer rifampin (600 mg/day for 14 days) resulted in an 11-fold decrease in aprepitant systemic exposure (AUC) and 3-fold decrease in the mean terminal half-life.
MANAGEMENT: The possibility of diminished therapeutic response to aprepitant should be considered during coadministration with CYP450 3A4 inducers, particularly potent ones like carbamazepine, enzalutamide, mitotane, phenobarbital, phenytoin, rifampin, and St. John's wort. Pharmacologic response to aprepitant should be monitored more closely whenever a CYP450 3A4 inducer is added to or withdrawn from therapy, and the dosage adjusted as necessary.
- "Product Information. Emend for Injection (fosaprepitant)." Merck & Company Inc, West Point, PA.
- "Product Information. Emend (aprepitant)." Merck & Company Inc, West Point, PA.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: carbamazepine
Brand name: Carbatrol, Epitol, Equetro, Tegretol, Tegretol XR, Tegretol, Tegretol XR
Synonyms: Carbamazepine, CarBAMazepine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Capsules-Carbamazepine Extended-Release Tablets
- Aprepitant Capsules-Carbamazepine Intravenous
- Aprepitant Capsules-Carbamazepine Oral Suspension
- Aprepitant Capsules-Carbamazepine Tablets
- Aprepitant Capsules-Carbaphen 12
- Aprepitant Capsules-Carbaphen CH
- Carbamazepine Extended-Release Capsules (Equetro)-Aprepitant Injection
- Carbamazepine Extended-Release Capsules (Equetro)-Aprepitant Intravenous
- Carbamazepine Extended-Release Capsules (Equetro)-Aprepitant Oral Suspension
- Carbamazepine Extended-Release Capsules (Equetro)-Aprepitant/Fosaprepitant Dimeglumine
- Carbamazepine Extended-Release Capsules (Equetro)-Apresazide
- Carbamazepine Extended-Release Capsules (Equetro)-Apresoline